Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 5 trials

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

3Total
Not Applicable (1)
P 1 (1)
P 4 (1)

Trial Status

Recruiting4
Not Yet Recruiting1

Clinical Trials (5)

Showing 5 of 5 trials
NCT07053917Phase 1Recruiting

Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability

NCT07319013Recruiting

AI-assisted Transcranial Duplex Sonography for Early Detection of Intracerebral Haemorrhage: HYPER-AI-SCAN

NCT07234955RecruitingPrimary

Minimally Invasive Surgery For Patients With Spontaneous Deep Intracerebral Hemorrhage

NCT06924983Phase 4Not Yet Recruiting

Neuroendoscopic Hematoma Evacuation Combined With Methylprednisolone Sodium Succinate in the Treatment of Basal Ganglia Intracerebral Hemorrhage at the Early Stage

NCT05539859Not ApplicableRecruitingPrimary

Efficacy and Safety of NeuroEndoscopic Surgery for IntraCerebral Hemorrhage

Showing all 5 trials

Research Network

Activity Timeline